 | • レポートコード：D0804-00621 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、136ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗腫瘍剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗腫瘍剤の種類別市場規模（化学療法、標的療法、免疫療法、ホルモン療法（生物学的療法）、その他）、用途別市場規模（血液がん、乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他のがん）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Takeda、Bristol-Myers Squibb、Novartis、Pfizer、Celgene、AstraZeneca、Johnson & Johnson、Amgen、Eli Lilly、Biogen Idec、Otsuka、Astellas、Ipsen、Eisai、Bayer、Merck & Co.、Merck KGaA、Teva、Sanofi、AbbVie、Gilead Sciences ・地域別グローバル市場分析 2015年-2020年 ・抗腫瘍剤の北米市場（アメリカ、カナダ、メキシコ） ・抗腫瘍剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗腫瘍剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗腫瘍剤の南米市場（ブラジル、アルゼンチン） ・抗腫瘍剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：化学療法、標的療法、免疫療法、ホルモン療法（生物学的療法）、その他 ・用途別分析：血液がん、乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他のがん ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Anti – Neoplastic Agents market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Anti – Neoplastic Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Anti – Neoplastic Agents market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anti – Neoplastic Agents market has been segmented into
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
By Application, Anti – Neoplastic Agents has been segmented into:
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti – Neoplastic Agents market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti – Neoplastic Agents markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti – Neoplastic Agents market.
The report offers in-depth assessment of the growth and other aspects of the Anti – Neoplastic Agents market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Anti – Neoplastic Agents Market Share Analysis
Anti – Neoplastic Agents competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti – Neoplastic Agents sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti – Neoplastic Agents sales, revenue and market share for each player covered in this report.
The major players covered in Anti – Neoplastic Agents are:
Roche
Takeda
Bristol-Myers Squibb
Novartis
Pfizer
Celgene
AstraZeneca
Johnson & Johnson
Amgen
Eli Lilly
Biogen Idec
Otsuka
Astellas
Ipsen
Eisai
Bayer
Merck & Co.
Merck KGaA
Teva
Sanofi
AbbVie
Gilead Sciences
Among other players domestic and global, Anti – Neoplastic Agents market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti – Neoplastic Agents product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti – Neoplastic Agents, with price, sales, revenue and global market share of Anti – Neoplastic Agents in 2018 and 2019.
Chapter 3, the Anti – Neoplastic Agents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti – Neoplastic Agents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Anti – Neoplastic Agents market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Anti – Neoplastic Agents sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Anti – Neoplastic Agents Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti – Neoplastic Agents Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy (Biologic Therapy)
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti – Neoplastic Agents Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Other Cancers
1.4 Overview of Global Anti – Neoplastic Agents Market
1.4.1 Global Anti – Neoplastic Agents Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Takeda SWOT Analysis
2.2.4 Takeda Product and Services
2.2.5 Takeda Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb SWOT Analysis
2.3.4 Bristol-Myers Squibb Product and Services
2.3.5 Bristol-Myers Squibb Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Celgene
2.6.1 Celgene Details
2.6.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Celgene SWOT Analysis
2.6.4 Celgene Product and Services
2.6.5 Celgene Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AstraZeneca SWOT Analysis
2.7.4 AstraZeneca Product and Services
2.7.5 AstraZeneca Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson & Johnson SWOT Analysis
2.8.4 Johnson & Johnson Product and Services
2.8.5 Johnson & Johnson Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Amgen SWOT Analysis
2.9.4 Amgen Product and Services
2.9.5 Amgen Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Eli Lilly SWOT Analysis
2.10.4 Eli Lilly Product and Services
2.10.5 Eli Lilly Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Biogen Idec
2.11.1 Biogen Idec Details
2.11.2 Biogen Idec Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Biogen Idec SWOT Analysis
2.11.4 Biogen Idec Product and Services
2.11.5 Biogen Idec Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Otsuka
2.12.1 Otsuka Details
2.12.2 Otsuka Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Otsuka SWOT Analysis
2.12.4 Otsuka Product and Services
2.12.5 Otsuka Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Astellas
2.13.1 Astellas Details
2.13.2 Astellas Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Astellas SWOT Analysis
2.13.4 Astellas Product and Services
2.13.5 Astellas Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Ipsen
2.14.1 Ipsen Details
2.14.2 Ipsen Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Ipsen SWOT Analysis
2.14.4 Ipsen Product and Services
2.14.5 Ipsen Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Eisai
2.15.1 Eisai Details
2.15.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Eisai SWOT Analysis
2.15.4 Eisai Product and Services
2.15.5 Eisai Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Bayer
2.16.1 Bayer Details
2.16.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Bayer SWOT Analysis
2.16.4 Bayer Product and Services
2.16.5 Bayer Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Merck & Co.
2.17.1 Merck & Co. Details
2.17.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Merck & Co. SWOT Analysis
2.17.4 Merck & Co. Product and Services
2.17.5 Merck & Co. Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Merck KGaA
2.18.1 Merck KGaA Details
2.18.2 Merck KGaA Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Merck KGaA SWOT Analysis
2.18.4 Merck KGaA Product and Services
2.18.5 Merck KGaA Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Teva
2.19.1 Teva Details
2.19.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Teva SWOT Analysis
2.19.4 Teva Product and Services
2.19.5 Teva Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Sanofi
2.20.1 Sanofi Details
2.20.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Sanofi SWOT Analysis
2.20.4 Sanofi Product and Services
2.20.5 Sanofi Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 AbbVie
2.21.1 AbbVie Details
2.21.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 AbbVie SWOT Analysis
2.21.4 AbbVie Product and Services
2.21.5 AbbVie Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.22 Gilead Sciences
2.22.1 Gilead Sciences Details
2.22.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Gilead Sciences SWOT Analysis
2.22.4 Gilead Sciences Product and Services
2.22.5 Gilead Sciences Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Anti – Neoplastic Agents Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Anti – Neoplastic Agents Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti – Neoplastic Agents Manufacturer Market Share in 2019
3.3.2 Top 6 Anti – Neoplastic Agents Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Anti – Neoplastic Agents Sales, Revenue and Market Share by Regions
4.1.1 Global Anti – Neoplastic Agents Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anti – Neoplastic Agents Revenue and Market Share by Regions (2015-2020)
4.2 North America Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
4.3 Europe Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
4.5 South America Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Anti – Neoplastic Agents Sales, Revenue and Market Share by Country
5.1.1 North America Anti – Neoplastic Agents Sales and Market Share by Country (2015-2020)
5.1.2 North America Anti – Neoplastic Agents Revenue and Market Share by Country (2015-2020)
5.2 United States Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
5.3 Canada Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
5.4 Mexico Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Anti – Neoplastic Agents Sales, Revenue and Market Share by Country
6.1.1 Europe Anti – Neoplastic Agents Sales and Market Share by Country (2015-2020)
6.1.2 Europe Anti – Neoplastic Agents Revenue and Market Share by Country (2015-2020)
6.2 Germany Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
6.3 UK Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
6.4 France Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
6.5 Russia Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
6.6 Italy Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anti – Neoplastic Agents Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Anti – Neoplastic Agents Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Anti – Neoplastic Agents Revenue and Market Share by Regions (2015-2020)
7.2 China Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
7.3 Japan Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
7.4 Korea Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
7.5 India Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
7.7 Australia Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Anti – Neoplastic Agents Sales, Revenue and Market Share by Country
8.1.1 South America Anti – Neoplastic Agents Sales and Market Share by Country (2015-2020)
8.1.2 South America Anti – Neoplastic Agents Revenue and Market Share by Country (2015-2020)
8.2 Brazil Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
8.3 Argentina Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anti – Neoplastic Agents Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Anti – Neoplastic Agents Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Anti – Neoplastic Agents Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
9.3 Turkey Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
9.4 Egypt Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
9.5 South Africa Anti – Neoplastic Agents Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Anti – Neoplastic Agents Sales and Market Share by Type (2015-2020)
10.2 Global Anti – Neoplastic Agents Revenue and Market Share by Type (2015-2020)
10.3 Global Anti – Neoplastic Agents Price by Type (2015-2020)
11 Global Anti – Neoplastic Agents Market Segment by Application
11.1 Global Anti – Neoplastic Agents Sales Market Share by Application (2015-2020)
11.2 Global Anti – Neoplastic Agents Revenue Market Share by Application (2015-2020)
11.3 Global Anti – Neoplastic Agents Price by Application (2015-2020)
12 Market Forecast
12.1 Global Anti – Neoplastic Agents Sales, Revenue and Growth Rate (2021-2025)
12.2 Anti – Neoplastic Agents Market Forecast by Regions (2021-2025)
12.2.1 North America Anti – Neoplastic Agents Market Forecast (2021-2025)
12.2.2 Europe Anti – Neoplastic Agents Market Forecast (2021-2025)
12.2.3 Asia-Pacific Anti – Neoplastic Agents Market Forecast (2021-2025)
12.2.4 South America Anti – Neoplastic Agents Market Forecast (2021-2025)
12.2.5 Middle East & Africa Anti – Neoplastic Agents Market Forecast (2021-2025)
12.3 Anti – Neoplastic Agents Market Forecast by Type (2021-2025)
12.3.1 Global Anti – Neoplastic Agents Sales Forecast by Type (2021-2025)
12.3.2 Global Anti – Neoplastic Agents Market Share Forecast by Type (2021-2025)
12.4 Anti – Neoplastic Agents Market Forecast by Application (2021-2025)
12.4.1 Global Anti – Neoplastic Agents Sales Forecast by Application (2021-2025)
12.4.2 Global Anti – Neoplastic Agents Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Anti - Neoplastic Agents Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti - Neoplastic Agents by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti - Neoplastic Agents Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Anti - Neoplastic Agents Major Business
Table 9. Roche Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 10. Roche SWOT Analysis
Table 11. Roche Anti - Neoplastic Agents Product and Services
Table 12. Roche Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Takeda Basic Information, Manufacturing Base and Competitors
Table 14. Takeda Anti - Neoplastic Agents Major Business
Table 15. Takeda Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 16. Takeda SWOT Analysis
Table 17. Takeda Anti - Neoplastic Agents Product and Services
Table 18. Takeda Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb Anti - Neoplastic Agents Major Business
Table 21. Bristol-Myers Squibb Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 22. Bristol-Myers Squibb SWOT Analysis
Table 23. Bristol-Myers Squibb Anti - Neoplastic Agents Product and Services
Table 24. Bristol-Myers Squibb Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis Basic Information, Manufacturing Base and Competitors
Table 26. Novartis Anti - Neoplastic Agents Major Business
Table 27. Novartis Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 28. Novartis SWOT Analysis
Table 29. Novartis Anti - Neoplastic Agents Product and Services
Table 30. Novartis Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Anti - Neoplastic Agents Major Business
Table 33. Pfizer Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 34. Pfizer SWOT Analysis
Table 35. Pfizer Anti - Neoplastic Agents Product and Services
Table 36. Pfizer Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Celgene Basic Information, Manufacturing Base and Competitors
Table 38. Celgene Anti - Neoplastic Agents Major Business
Table 39. Celgene Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 40. Celgene SWOT Analysis
Table 41. Celgene Anti - Neoplastic Agents Product and Services
Table 42. Celgene Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Anti - Neoplastic Agents Major Business
Table 45. AstraZeneca Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 46. AstraZeneca SWOT Analysis
Table 47. AstraZeneca Anti - Neoplastic Agents Product and Services
Table 48. AstraZeneca Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 50. Johnson & Johnson Anti - Neoplastic Agents Major Business
Table 51. Johnson & Johnson Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 52. Johnson & Johnson SWOT Analysis
Table 53. Johnson & Johnson Anti - Neoplastic Agents Product and Services
Table 54. Johnson & Johnson Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Amgen Basic Information, Manufacturing Base and Competitors
Table 56. Amgen Anti - Neoplastic Agents Major Business
Table 57. Amgen Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 58. Amgen SWOT Analysis
Table 59. Amgen Anti - Neoplastic Agents Product and Services
Table 60. Amgen Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 62. Eli Lilly Anti - Neoplastic Agents Major Business
Table 63. Eli Lilly Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 64. Eli Lilly SWOT Analysis
Table 65. Eli Lilly Anti - Neoplastic Agents Product and Services
Table 66. Eli Lilly Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 68. Biogen Idec Anti - Neoplastic Agents Major Business
Table 69. Biogen Idec Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 70. Biogen Idec SWOT Analysis
Table 71. Biogen Idec Anti - Neoplastic Agents Product and Services
Table 72. Biogen Idec Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Otsuka Basic Information, Manufacturing Base and Competitors
Table 74. Otsuka Anti - Neoplastic Agents Major Business
Table 75. Otsuka Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 76. Otsuka SWOT Analysis
Table 77. Otsuka Anti - Neoplastic Agents Product and Services
Table 78. Otsuka Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Astellas Basic Information, Manufacturing Base and Competitors
Table 80. Astellas Anti - Neoplastic Agents Major Business
Table 81. Astellas Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 82. Astellas SWOT Analysis
Table 83. Astellas Anti - Neoplastic Agents Product and Services
Table 84. Astellas Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Ipsen Basic Information, Manufacturing Base and Competitors
Table 86. Ipsen Anti - Neoplastic Agents Major Business
Table 87. Ipsen Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 88. Ipsen SWOT Analysis
Table 89. Ipsen Anti - Neoplastic Agents Product and Services
Table 90. Ipsen Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Eisai Basic Information, Manufacturing Base and Competitors
Table 92. Eisai Anti - Neoplastic Agents Major Business
Table 93. Eisai Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 94. Eisai SWOT Analysis
Table 95. Eisai Anti - Neoplastic Agents Product and Services
Table 96. Eisai Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Bayer Basic Information, Manufacturing Base and Competitors
Table 98. Bayer Anti - Neoplastic Agents Major Business
Table 99. Bayer Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 100. Bayer SWOT Analysis
Table 101. Bayer Anti - Neoplastic Agents Product and Services
Table 102. Bayer Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 104. Merck & Co. Anti - Neoplastic Agents Major Business
Table 105. Merck & Co. Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 106. Merck & Co. SWOT Analysis
Table 107. Merck & Co. Anti - Neoplastic Agents Product and Services
Table 108. Merck & Co. Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Merck KGaA Anti - Neoplastic Agents Type and Application
Table 110. Merck KGaA Anti - Neoplastic Agents Major Business
Table 111. Merck KGaA Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 112. Merck KGaA SWOT Analysis
Table 113. Merck KGaA Anti - Neoplastic Agents Product and Services
Table 114. Merck KGaA Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Teva Basic Information, Manufacturing Base and Competitors
Table 116. Teva Anti - Neoplastic Agents Major Business
Table 117. Teva Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 118. Teva SWOT Analysis
Table 119. Teva Anti - Neoplastic Agents Product and Services
Table 120. Teva Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Sanofi Basic Information, Manufacturing Base and Competitors
Table 122. Sanofi Anti - Neoplastic Agents Major Business
Table 123. Sanofi Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 124. Sanofi SWOT Analysis
Table 125. Sanofi Anti - Neoplastic Agents Product and Services
Table 126. Sanofi Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. AbbVie Basic Information, Manufacturing Base and Competitors
Table 128. AbbVie Anti - Neoplastic Agents Major Business
Table 129. AbbVie Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 130. AbbVie SWOT Analysis
Table 131. AbbVie Anti - Neoplastic Agents Product and Services
Table 132. AbbVie Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 133. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 134. Gilead Sciences Anti - Neoplastic Agents Major Business
Table 135. Gilead Sciences Anti - Neoplastic Agents Total Revenue (USD Million) (2017-2018)
Table 136. Gilead Sciences SWOT Analysis
Table 137. Gilead Sciences Anti - Neoplastic Agents Product and Services
Table 138. Gilead Sciences Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 139. Global Anti - Neoplastic Agents Sales by Manufacturer (2018-2019) (K Units)
Table 140. Global Anti - Neoplastic Agents Revenue by Manufacturer (2018-2019) (USD Million)
Table 141. Global Anti - Neoplastic Agents Sales by Regions (2015-2020) (K Units)
Table 142. Global Anti - Neoplastic Agents Sales Market Share by Regions (2015-2020)
Table 143. Global Anti - Neoplastic Agents Revenue by Regions (2015-2020) (USD Million)
Table 144. North America Anti - Neoplastic Agents Sales by Countries (2015-2020) (K Units)
Table 145. North America Anti - Neoplastic Agents Sales Market Share by Countries (2015-2020)
Table 146. North America Anti - Neoplastic Agents Revenue by Countries (2015-2020) (USD Million)
Table 147. North America Anti - Neoplastic Agents Revenue Market Share by Countries (2015-2020)
Table 148. Europe Anti - Neoplastic Agents Sales by Countries (2015-2020) (K Units)
Table 149. Europe Anti - Neoplastic Agents Sales Market Share by Countries (2015-2020)
Table 150. Europe Anti - Neoplastic Agents Revenue by Countries (2015-2020) (USD Million)
Table 151. Asia-Pacific Anti - Neoplastic Agents Sales by Regions (2015-2020) (K Units)
Table 152. Asia-Pacific Anti - Neoplastic Agents Sales Market Share by Regions (2015-2020)
Table 153. Asia-Pacific Anti - Neoplastic Agents Revenue by Regions (2015-2020) (USD Million)
Table 154. South America Anti - Neoplastic Agents Sales by Countries (2015-2020) (K Units)
Table 155. South America Anti - Neoplastic Agents Sales Market Share by Countries (2015-2020)
Table 156. South America Anti - Neoplastic Agents Revenue by Countries (2015-2020) (USD Million)
Table 157. South America Anti - Neoplastic Agents Revenue Market Share by Countries (2015-2020)
Table 158. Middle East & Africa Anti - Neoplastic Agents Sales by Countries (2015-2020) (K Units)
Table 159. Middle East & Africa Anti - Neoplastic Agents Sales Market Share by Countries (2015-2020)
Table 160. Middle East & Africa Anti - Neoplastic Agents Revenue by Countries (2015-2020) (USD Million)
Table 161. Middle East & Africa Anti - Neoplastic Agents Revenue Market Share by Countries (2015-2020)
Table 162. Global Anti - Neoplastic Agents Sales by Type (2015-2020) (K Units)
Table 163. Global Anti - Neoplastic Agents Sales Share by Type (2015-2020)
Table 164. Global Anti - Neoplastic Agents Revenue by Type (2015-2020) (USD Million)
Table 165. Global Anti - Neoplastic Agents Revenue Share by Type (2015-2020)
Table 166. Global Anti - Neoplastic Agents Sales by Application (2015-2020) (K Units)
Table 167. Global Anti - Neoplastic Agents Sales Share by Application (2015-2020)
Table 168. Global Anti - Neoplastic Agents Sales Forecast by Regions (2021-2025) (K Units)
Table 169. Global Anti - Neoplastic Agents Market Share Forecast by Regions (2021-2025)
Table 170. Global Anti - Neoplastic Agents Sales Forecast by Type (2021-2025) (K Units)
Table 171. Global Anti - Neoplastic Agents Market Share Forecast by Type (2021-2025)
Table 172. Global Anti - Neoplastic Agents Sales Forecast by Application (2021-2025)
Table 173. Global Anti - Neoplastic Agents Market Share Forecast by Application (2021-2025)
Table 174. Direct Channel Pros & Cons
Table 175. Indirect Channel Pros & Cons
Table 176. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Anti - Neoplastic Agents Picture
Figure 2. Global Sales Market Share of Anti - Neoplastic Agents by Type in 2019
Figure 3. Chemotherapy Picture
Figure 4. Targeted Therapy Picture
Figure 5. Immunotherapy Picture
Figure 6. Hormonal Therapy (Biologic Therapy) Picture
Figure 7. Others Picture
Figure 8. Anti - Neoplastic Agents Sales Market Share by Application in 2018
Figure 9. Blood Cancer Picture
Figure 10. Breast Cancer Picture
Figure 11. Gastrointestinal Cancer Picture
Figure 12. Prostate Cancer Picture
Figure 13. Respiratory/Lung Cancer Picture
Figure 14. Other Cancers Picture
Figure 15. Global Anti - Neoplastic Agents Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Anti - Neoplastic Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Anti - Neoplastic Agents Sales Market Share by Manufacturer in 2019
Figure 36. Global Anti - Neoplastic Agents Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Anti - Neoplastic Agents Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Anti - Neoplastic Agents Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 41. Global Anti - Neoplastic Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Anti - Neoplastic Agents Revenue Market Share by Regions (2015-2020)
Figure 43. Global Anti - Neoplastic Agents Revenue Market Share by Regions in 2018
Figure 44. North America Anti - Neoplastic Agents Sales and Growth Rate (2015-2020)
Figure 45. Europe Anti - Neoplastic Agents Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Anti - Neoplastic Agents Sales and Growth Rate (2015-2020)
Figure 47. South America Anti - Neoplastic Agents Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Anti - Neoplastic Agents Sales and Growth Rate (2015-2020)
Figure 49. North America Anti - Neoplastic Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Anti - Neoplastic Agents Sales Market Share by Countries (2015-2020)
Figure 51. North America Anti - Neoplastic Agents Sales Market Share by Countries in 2018
Figure 52. North America Anti - Neoplastic Agents Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Anti - Neoplastic Agents Revenue Market Share by Countries in 2018
Figure 54. United States Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Canada Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Mexico Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Europe Anti - Neoplastic Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Anti - Neoplastic Agents Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Anti - Neoplastic Agents Revenue Market Share by Countries in 2019
Figure 60. Germany Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 61. UK Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 62. France Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Russia Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Italy Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Asia-Pacific Anti - Neoplastic Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Anti - Neoplastic Agents Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Anti - Neoplastic Agents Revenue Market Share by Regions 2019
Figure 68. China Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Japan Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Korea Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 71. India Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Southeast Asia Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 73. South America Anti - Neoplastic Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Anti - Neoplastic Agents Sales Market Share by Countries in 2019
Figure 75. South America Anti - Neoplastic Agents Revenue Market Share by Countries in 2019
Figure 76. Brazil Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Argentina Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Middle East and Africa Anti - Neoplastic Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Anti - Neoplastic Agents Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Anti - Neoplastic Agents Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Anti - Neoplastic Agents Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Egypt Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Turkey Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 85. South Africa Anti - Neoplastic Agents Sales and Growth Rate (2015-2020) (K Units)
Figure 86. Global Anti - Neoplastic Agents Sales and Growth Rate (2021-2025) (K Units)
Figure 87. Global Anti - Neoplastic Agents Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Anti - Neoplastic Agents Market Forecast (2021-2025) (K Units)
Figure 89. Europe Sales Anti - Neoplastic Agents Market Forecast (2021-2025) (K Units)
Figure 90. Asia-Pacific Sales Anti - Neoplastic Agents Market Forecast (2021-2025) (K Units)
Figure 91. South America Sales Anti - Neoplastic Agents Market Forecast (2021-2025) (K Units)
Figure 92. Middle East & Africa Sales Anti - Neoplastic Agents Market Forecast (2021-2025) (K Units)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
植物源抗がん剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Plant Sources Anti Cancer Agents market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Plant Source…- アスファルト剥離防止剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Asphalt Anti-Stripping Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- アスファルト剥離防止剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Asphalt Anti-Stripping Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 転移性乳がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Breast Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastatic…
- 抗腫瘍薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-tumor Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…